Silvaco Group Inc 2025年季度报告

As of May 5, 2025 the registrant had29,385,444shares of common stock, $0.0001 par value per share, outstanding. Condensed Consolidated Balance SheetsCondensed ConsolidatedStatements of (Loss) IncomeCondensed ConsolidatedStatements of Comprehensive (Loss) Income Condensed ConsolidatedStatements of Cash FlowsNotes to the Condensed Consolidated Financial Statements Management’s Discussion and Analysis of Financial Condition and Results of OperationsQuantitative and Qualitative Disclosures About Market Risk Maturities of marketable securities Net cash provided by (used in) investing activitiesCash flows from financing activities: Proceeds from loan facility—Deferred transaction costs—Payroll taxes related to shares withheld from employees(252)Contingent consideration(46)Payments of vendor financing obligation(205)Net cash (used in) provided by financing activities(503)Effect of exchange rate fluctuations on cash and cash equivalents117 NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Unaudited)1.Description of Business decades of expertise developing the “technology behind the chip” and providing solutions that span from atoms to systems,starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing chip (“SoC”), integrated circuits (“ICs”) and SIP management tools to enable team collaborations on complex SoC designs. TheCompany’s customers include semiconductor manufacturers, original equipment manufacturers (“OEMs”) and design teams who deploy the Company’s solutions in production flows across the Company’s target markets, including display, power devices,automotive, memory, high performance computing (“HPC”), internet of things (“IoT”) and 5G/6G mobile markets.2.Summary of Significant Accounting and Reporting Policies accordance with GAAP have been omitted from these condensed consolidated financial statements, as permitted by Securitiesand Exchange Commission (“SEC”) rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31,2024 and the related notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2025.The condensed consolidated balance sheet as of December 31, 2024 was derived from the audited consolidated financialstatements as of that date. In management’s opinion, the condensed consolidated financial statements have been prepared on The results of operations for the three months ended March31, 2025 are not necessarily indicative of the Company’s operatingresults to be expected for the full fiscal year or any other future interim or annual period. Emerging growth company status affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financialstatements. Estimates also affect the amounts of revenue and expenses during the reported periods. The Company’s mostsignificantestimates relate to revenue recognition.Other estimates include,but are not limited to,accounts receivableallowances, stock-based compensation expense, valuation of goodwill and other intangible assets, contingent consideration, Concentrations of credit riskAccounts receivable from customers representing 10% or more of the Company’s total accounts receivable were as follows: Customer A Customer CCustomer D *21%Customer E*15%* Customer accounted for less than 10% of total accounts receivable at period end. * Customer accounted for less than 10% of total revenue during the period.In addition to the concentration of credit risk with respect to trade receivables and revenue, the Company's cash on deposit withfinancial institutions is also exposed to concentration risk. The Company's cash on deposit with financial institutions is insured the Company’s foreign subsidiaries. Accumulated other comprehensive lossAccumulated other comprehensive loss is composed of foreign currency translation adjustments and unrealized gains and Foreign currenciesThe financial statements of Silvaco's international subsidiaries with local functional currencies are translated to U.S. dollars upon 7 recorded in functional currency at the appropriate exchange rate on the transaction date. Monetary assets and liabilitiesdenominatedin a currency other than the Company's functional currency or its subsidiaries'functional currencies are transactions are included in interest and other expense, net in the Company’s condensed consolidated statements of (loss)income.The Company recorded net foreign exchange transaction losses of $0.2million and $0.1million for the three monthsended March31, 2025 and 2024, respectively.Net (loss) income per share The following outstanding securities were excluded from the computation of diluted net (loss) income per share because (i) theeffect would be anti-dilutive for the three months e